comparemela.com

Latest Breaking News On - Antonin de fougerolles - Page 1 : comparemela.com

Evox Therapeutics publishes new research identifying 'potent' scaffold proteins

Evox Therapeutics, an exosome therapeutics company, has announced the publication of its research identifying novel exosome scaffold proteins that significantly improve drug loading into exosomes for therapeutic purposes.

Nature-communications
Antonin-de-fougerolles
Bio-developments
Pipelines
Proteins
Engineering
Manufacturing
Exosomes

Landmark paper in Nature Communications highlights continued advances in Evox Therapeutics's proprietary exosome engineering platform

OXFORD, United Kingdom, Aug. 09, 2023 (GLOBE NEWSWIRE) Evox Therapeutics Ltd ('Evox'), a leading exosome therapeutics company, today announced the publication in Nature Communications of Evox-funded research

United-kingdom
Redmile
Leicestershire
Simon-conway-natalie
Evox-therapeutics-ltd
Therapeutics-ltd
Nature-communications
Antonin-de-fougerolles
Chief-executive-officer

EVOX THERAPEUTICS LIMITED: Landmark paper in Nature Communications highlights continued advances in Evox Therapeutics's proprietary exosome engineering platform

EVOX THERAPEUTICS LIMITED: Landmark paper in Nature Communications highlights continued advances in Evox Therapeutics's proprietary exosome engineering platform
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Redmile
Leicestershire
United-kingdom
Simon-conway-natalie
Antonin-de-fougerolles
Chief-executive-officer
Aktien-sie

Evox Therapeutics reaches gene therapy agreement

Evox Therapeutics reaches gene therapy agreement
pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.

Susmita-sahoo
Icahn-school-of-medicine
Icahn-school
New-york-based-icahn-school
Icahn-mount-sinai
Antonin-de-fougerolles

Evox Therapeutics to advance gene therapy for treatment of heart disease

Evox Therapeutics, an exosome therapeutics company, has announced a research collaboration and option agreement with the Icahn School of Medicine at Mount Sinai in New York, US.

Susmita-sahoo
Icahn-mount-sinai
Antonin-de-fougerolles
Bio-developments
Emerging-markets
Gene
Gene-therapy
Heart

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.